Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study)
Status:
Completed
Trial end date:
2016-11-22
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine if eculizumab is safe and could be used to prevent
delayed graft function (DGF) following kidney transplantation.